Parameter
| Biomarker | mePENK | Full name | Methylated proenkephalin gene | Molecular Type | Nucleic acid (DNA methylation) |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Early diagnosis |
| Disease | Bladder Cancer (BC) | Disease Subtypes | / | ||
| Organ | Bladder | Test Sample / Technology Platform | Urine (exact methylation platform not specified) | ||
| Pathobiological Mechanisms | Early epigenetic event in BCa; methylation status in urine serves as a non-invasive biomarker for early detection and improves detection efficacy | ||||
| Clinical Availability Status | Research verification stage: focused on early BCa; large-sample validation required | ||||
| Notes and Dynamics | Pro-enkephalin gene offering an important epigenetic urine marker for early non-invasive diagnosis of BCa | ||||